-transparent.png){kind=logo}
This report presents the analysis of leukemic relapse of 52 patients who received allogeneic bone marrow transplantation between July 1984 and May 1990. Conditioning regimen consisted of TBI + CY and GVHD prophylaxis consisted of cyclosporin-A and methotrexate. The relapse ratios of chronic myelogenous leukemia (CML) (21 in chronic phase, 1 in accelerated phase, 1 in blastic crisis), acute nonlymphocytic leukemia (ANLL) (all 17 in 1st CR), acute lymphocytic leukemia (ALL) (all 12 in 1st CR) were 13%, 18%, 25%, respectively, and 3 year disease free survival (DFS) was as follows, CML 68%, ANLL 72%, ALL 49%. Regarding acute GVHD grading and chronic GVHD presence, 3 year DFS was as follows, acute GVHD 0 degree: 59%, I degree: 78%, II degree-IV degree: 53%, chronic GVHD (+): 82% GVHD (-): 77%. In our center leukemic relapse has been the major cause of death after BMT since 1984. Among 9 relapsed cases, one recurred more than 3 years after BMT, and another one got recurrent leukemia of donor origin.
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
August 1978,
Blood,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
January 1996,
Cancer treatment and research,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
February 1987,
Transplantation proceedings,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
January 1996,
Cancer detection and prevention,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
February 1994,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
August 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
December 1994,
Blood,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
November 1997,
Bone marrow transplantation,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
March 2000,
Clinics in laboratory medicine,
M Yoshimura, and
H Yoshida, and
T Matsunashi, and
S Hidaka, and
M Kobayashi, and
S Yoshida, and
N Tominaga, and
H Tejima, and
A Hiraoka, and
H Nakamura
January 1995,
Nouvelle revue francaise d'hematologie,
